Lisondra, Clara E.
HRN: 28-99-30 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2026
CEFTRIAXONE 1G (VIAL)
05/12/2026
05/19/2026
IV
2g
Od
Uti
Checking Initial Appropriateness
05/12/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/12/2026
05/19/2026
IV
500mg
Q8
Amoebiasis Intestinal
Checking Initial Appropriateness
05/12/2026
AZITHROMYCIN 500MG TABLET (TAB)
05/12/2026
05/16/2026
PO
500mg
Od
Cap Lr
Checking Initial Appropriateness